Nicotine alters mucin rheological properties

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 307, Issue 2, 2014, Pages

  Chen, Eric Y ^a,b,c   Sun, Albert ^a   Chen, Chi Shuo ^a   Mintz, Alexander J ^a   Chin, Wei Chun ^a  

^a University of California   (United States)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c Micro Base Technology Corp   (Taiwan)

Author keywords

Chronic obstructive pulmonary disease; Environmental tobacco smoke; Mucin swelling kinetics; Mucociliary clearance; Tobacco smoke; Viscosity

Indexed keywords

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; ENVIRONMENTAL TOBACCO SMOKE; MUCIN SWELLING KINETICS; MUCOCILIARY CLEARANCE; TOBACCO SMOKE; VISCOSITY;

ANIMALS; CELLS, CULTURED; EPITHELIAL CELLS; GELS; HUMANS; MUCINS; MUCUS; NICOTINE; PARTICLE SIZE; RHEOLOGY; SMOKING; SWINE; VISCOSITY;

EID: 84904292642     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00396.2012     Document Type: Article

References (58)

1. 2+ activation of mucin secretion in airway goblet cells. Am J Physiol Lung Cell Mol Physiol 273: L201-L210, 1997.
2. Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration 81: 265-284, 2011.
3. Barnes PJ. New treatments for COPD. Nat Rev Drug Discov 1: 437-446, 2002.
4. Betsuyaku T, Fuke S, Inomata T, Kaga K, Morikawa T, Odajima N, Adair-Kirk T, Nishimura M. Bronchiolar epithelial catalase is diminished in smokers with mild COPD. Eur Respir J 42: 42-53, 2013.
5. Bolte G, Heitmann D, Kiranoglu M, Schierl R, Diemer J, Koerner W, Fromme H. Exposure to environmental tobacco smoke in German restaurants, pubs and discotheques. J Expo Sci Environ Epidemiol 18: 262-271, 2008.
6. Bromberg LE, Barr DP. Self-association of mucin. Biomacromolecules 1: 325-334, 2000.
7. Button B, Cai LH, Ehre C, Kesimer M, Hill DB, Sheehan JK, Boucher RC, Rubinstein M. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 337: 937-941, 2012.
8. Caldwell B, Sumner W, Crane J. A systematic review of nicotine by inhalation: is there a role for the inhaled route? Nicotine Tob Res 14: 1127-1139, 2012.
9. Cantin AM. Cellular response to cigarette smoke and oxidants: adapting to survive. Proc Am Thorac Soc 7: 368-375, 2010.
10. Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, Zielenski J, Durie P. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med 173: 1139-1144, 2006.
11. Carlstedt I, Sheehan JK. Is the macromolecular architecture of cervical, respiratory and gastric mucins the same? Biochem Soc Trans 12: 615-617, 1984.
12. Cerveri I, Brusasco V. Revisited role for mucus hypersecretion in the pathogenesis of COPD. Eur Respir Rev 19: 109-112, 2010.
13. Chen EY, Yang N, Quinton PM, Chin WC. A new role for bicarbonate in mucus formation. Am J Physiol Lung Cell Mol Physiol 299: L542-L549, 2010.
14. Clunes LA, Bridges A, Alexis N, Tarran R. In vivo vs. in vitro airway surface liquid nicotine levels following cigarette smoke exposure. J Anal Toxicol 32: 201-207, 2008.
15. Clunes LA, Davies CM, Coakley RD, Aleksandrov AA, Henderson AG, Zeman KL, Worthington EN, Gentzsch M, Kreda SM, Cholon D, Bennett WD, Riordan JR, Boucher RC, Tarran R. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J 26: 533-545, 2012.
16. Duvvuri M, Krise JP. A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pHpartitioning theory would predict. Mol Pharm 2: 440-448, 2005.
17. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med 363: 2233-2247, 2010.
18. Flouris AD, Metsios GS, Carrillo AE, Jamurtas AZ, Gourgoulianis K, Kiropoulos T, Tzatzarakis MN, Tsatsakis AM, Koutedakis Y. Acute and short-term effects of secondhand smoke on lung function and cytokine production. Am J Respir Crit Care Med 179: 1029-1033, 2009.
19. Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 57: 967-972, 2002.
20. + exchange stimulates vesicular glutamate transport. Nat Neurosci 14: 1285-1292, 2011.
21. Gouaze V, Dousset N, Dousset JC, Valdiguie P. Effect of nicotine and cotinine on the susceptibility to in vitro oxidation of LDL in healthy non smokers and smokers. Clin Chim Acta 277: 25-37, 1998.
22. Heijink IH, de Bruin HG, van den Berge M, Bennink LJ, Brandenburg SM, Gosens R, van Oosterhout AJ, Postma DS. Role of aberrant WNT signalling in the airway epithelial response to cigarette smoke in chronic obstructive pulmonary disease. Thorax 68: 709-716, 2013.
23. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364: 709-721, 2004.
24. Hogg JC, Chu FS, Tan WC, Sin DD, Patel SA, Pare PD, Martinez FJ, Rogers RM, Make BJ, Criner GJ, Cherniack RM, Sharafkhaneh A, Luketich JD, Coxson HO, Elliott WM, Sciurba FC. Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med 176: 454-459, 2007.
25. Hureaux J, Drouet M, Urban T. A case report of subacute bronchial toxicity induced by an electronic cigarette. Thorax 69: 596-597, 2014.
26. Iravani J, Melville GN. Long-term effect of cigarette smoke on mucociliary function in animals. Respiration 31: 358-366, 1974.
27. Kesimer M, Makhov AM, Griffith JD, Verdugo P, Sheehan JK. Unpacking a gel-forming mucin: a view of MUC5B organization after granular release. Am J Physiol Lung Cell Mol Physiol 298: L15-L22, 2010.
28. Kirkham S, Kolsum U, Rousseau K, Singh D, Vestbo J, Thornton D. MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178: 1033-1039, 2008.
29. Lai H, Rogers DF. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways. J Aerosol Med Pulm Drug Deliv 23: 219-231, 2010.
30. Lai SK, O'Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, Hanes J. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci USA 104: 1482-1487, 2007.
31. Lang M, Hummer B, Hahn HL. Effect of systemic nicotine on mucus secretion from tracheal submucosal glands and on cardiovascular, pulmonary, and hematologic variables. Klin Wochenschr 66, Suppl 11: 170-179, 1988.
32. Macnee W. Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med 28: 479-513, v, 2007.
33. Mayol L, Quaglia F, Borzacchiello A, Ambrosio L, La Rotonda MI. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties. Eur J Pharm Biopharm 70: 199-206, 2008.
34. 2+. Nature 395: 908-912, 1998.
35. Nielsen HM, Rassing MR. Nicotine permeability across the buccal TR146 cell culture model and porcine buccal mucosa in vitro: effect of pH and concentration. Eur J Pharm Sci 16: 151-157, 2002.
36. Ohkuma S, Poole B. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J Cell Biol 90: 656-664, 1981.
37. + from mast cell secretory granules: implications for signal transduction. Biophys J 85: 963-970, 2003.
38. Randell SH, Boucher RC; University of North Carolina Virtual Lung Group. Effective mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol 35: 20-28, 2006.
39. Rose MC, Piazza FM, Chen YA, Alimam MZ, Bautista MV, Letwin N, Rajput B. Model systems for investigating mucin gene expression in airway diseases. J Aerosol Med 13: 245-261, 2000.
40. Ruben Z, Dodd DC, Rorig KJ, Anderson SN. Disobutamide: a model agent for investigating intracellular drug storage. Toxicol Appl Pharmacol 97: 57-71, 1989.
41. Rubinstein M. Discretized model of entangled-polymer dynamics. Phys Rev Lett 59: 1946-1949, 1987.
42. Saetta M, Turato G, Baraldo S, Zanin A, Braccioni F, Mapp CE, Maestrelli P, Cavallesco G, Papi A, Fabbri LM. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 161: 1016-1021, 2000.
43. Sallette J, Pons S, Devillers-Thiery A, Soudant M, Prado de Carvalho L, Changeux JP, Corringer PJ. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46: 595-607, 2005.
44. Schuh KJ, Schuh LM, Henningfield JE, Stitzer ML. Nicotine nasal spray and vapor inhaler: abuse liability assessment. Psychopharmacology (Berl) 130: 352-361, 1997.
45. Serisier DJ, Carroll MP, Shute JK, Young SA. Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum. Respir Res 10: 63, 2009.
46. Sheehan JK, Oates K, Carlstedt I. Electron microscopy of cervical, gastric and bronchial mucus glycoproteins. Biochem J 239: 147-153, 1986.
47. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372-377, 2002.
48. Sriamornsak P, Wattanakorn N, Takeuchi H. Study on the mucoadhesion mechanism of pectin by atomic force microscopy and mucin-particle method. Carbohydrate Polymers 79: 54-59, 2010.
49. Tanaka T, Fillmore D. Kinetics of swelling of gels. J Chem Phys 70: 1214-1218, 1979.
50. Thornton DJ, Davies JR, Kraayenbrink M, Richardson PS, Sheehan JK, Carlstedt I. Mucus glycoproteins from 'normal' human tracheobronchial secretion. Biochem J 265: 179-186, 1990.
51. Thornton DJ, Sheehan JK. From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc Am Thorac Soc 1: 54-61, 2004.
52. Totti N 3rd, McCusker KT, Campbell EJ, Griffin GL, Senior RM. Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. Science 223: 169-171, 1984.
53. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 141: 1400-1406, 2012.
54. Verdugo P. Goblet cells secretion and mucogenesis. Annu Rev Physiol 52: 157-176, 1990.
55. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 153: 1530-1535, 1996.
56. Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest 135: 505-512, 2009.
57. Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, Zhang WS, Thomas GN, Adab P. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet 370: 751-757, 2007.
58. Yuan-Chen Wu D, Wu R, Reddy SP, Lee YC, Chang MM. Distinctive epidermal growth factor receptor/extracellular regulated kinase-independent and-dependent signaling pathways in the induction of airway mucin 5B and mucin 5AC expression by phorbol 12-myristate 13-acetate. Am J Pathol 170: 20-32, 2007.